Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms cis-1-[4-(Hydroxymethyl)-2-cyclopenten-1-yl]-5-[124I]iodouracil |
Target |
Action modulators |
Mechanism thymidine kinase modulators(Thymidine kinase modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC10H11IN2O3 |
InChIKeyFIGOIHRJINUHNT-AEQHHNBMSA-N |
CAS Registry960286-37-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Simplex | Discovery | South Korea | 26 Oct 2007 |